Effect of Self-directed and Supervised Pulmonary Rehabilitation Approach on Cough and Sputum.

NCT ID: NCT05538975

Last Updated: 2022-09-14

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

40 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-02-23

Study Completion Date

2022-08-21

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Chronic obstructive pulmonary disease (COPD)is a multifactorial, progressive chronic lung disease that causes airflow restriction. Study was conducted To Compare the effects of supervised and self-directed pulmonary rehabilitation on cough and sputum expectoration in patients of chronic obstructive pulmonary disease.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

To Compare the effects of supervised and self-directed pulmonary rehabilitation on cough and sputum expectoration in patients of chronic obstructive pulmonary disease. It was a randomised control trial and participants were COPD Patients.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

COPD Pulmonary Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group A

home based plan of aerobic exercises, strengthening exercises of upper and lower limbs and huffing and coughing

Group Type EXPERIMENTAL

Physiotherapy Treatment

Intervention Type OTHER

Pulmonary Rehabilitation Techniques

Group B

Supervised aerobic exercises, strengthening exercises of upper and lower limbs and huffing and coughing

Group Type PLACEBO_COMPARATOR

Physiotherapy Treatment

Intervention Type OTHER

Pulmonary Rehabilitation Techniques

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Physiotherapy Treatment

Pulmonary Rehabilitation Techniques

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age: 40 to 60
* Gender: Both Males \& Females.
* Diagnoses with an exacerbation of COPD.
* Informed consent obtained.

Exclusion Criteria

* Inability to provide informed consent or complete a self-administered questionnaire.
* Patients with trauma.
* Females who were pregnant and breastfeeding.
Minimum Eligible Age

40 Years

Maximum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Afridi Medical Complex

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Usman Farooq

Consultant

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Syed Alamdar Hussain, Phd

Role: STUDY_DIRECTOR

Afridi Medical Complex

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Pulmonary Rehabilitation

Peshawar, Khyber Pakhtunkhwa, Pakistan

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Pakistan

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

0112

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.